Filed in archive
Corporate and Industrial News
by ruth on November 30, 2007
According to the national venture capital association, venture capital investing in the biotechnology arena continue to be robust.
As before, there is however a reluctance from VCs to back early-stage ventures. Read the full report from BioWorld.
Biotechnology had $1.1 billion going into 99 deals in the third quarter, Heesen told BioWorld Today. VCs invested $1.2 billion in biotech in 124 deals in the second quarter, and in the first quarter, "the strongest quarter ever recorded for the amount of money" for biotech, VCs invested $1.5 billion in 106 deals, he added.
As before, there is however a reluctance from VCs to back early-stage ventures. Read the full report from BioWorld.
Permalink: Biotech Still Attract VC Investors
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/104614
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Biotech Still Attract VC Investors:
|
Rating: 9.00 out of 1 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
